CClinicalTrials.gg
Status unknownNCT01557205Updated Mar 19, 2012

Research and System Development on Functional 3D Optical Tomography for Skin Cell Imaging

An observational study in Optical Coherence Tomography and Skin Cell Imaging, sponsored by National Taiwan University Hospital. Status unknown. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2012-03-19.

Sponsored by National Taiwan University Hospital · Observational

The sponsor has not verified this record recently (last verified Mar 2012), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Enrollment
30
Ages
20 Years and older
Sex
All
01

Study summary

The investigators will obtain human skin specimen (sized approximately 1 cm x 1 cm) for dermatological surgical patients in National Taiwan University Hospital, after informed consent was obtained. Human skin keratinocytes, fibroblasts, and melanocytes will be cultured from the human skin specimen. The three dimensional images of these cultured cells will be observed by a ultra-high resolution 3-dimensional optical coherence tomography.

Read the detailed description

The investigators will obtain human skin specimen (sized approximately 1 cm x 1 cm) for dermatological surgical patients in National Taiwan University Hospital, after informed consent was obtained. Human skin keratinocytes, fibroblasts, and melanocytes will be cultured from the human skin specimen. The three dimensional images of these cultured cells will be observed by a ultra-high resolution 3-dimensional optical coherence tomography.

02

Conditions studied

  • Optical Coherence Tomography
  • Skin Cell Imaging

Keywords

  • optical coherence tomography
  • cell imaging
03

In context

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Aged between 20 to 100. People who received benign skin tumor removal in dermatological surgical unit. OR people who received skin grafts (full thickness or split thickness) for reconstruction of surgical wounds after removing malignant skin cancer.

Inclusion criteria

  • Aged between 20 to 100.
  • People who received benign skin tumor removal in dermatological surgical unit. OR
  • People who received skin grafts (full thickness or split thickness) for reconstruction of surgical wounds after removing malignant skin cancer.

Exclusion criteria

Exclusion Criteria:

  • Age less than 20 years old,
  • Psychiatric patients,
  • Pregnant women.
05

Study design

Enrollment
30 participants (estimated)
Biospecimen retention
None retained
06

Study locations

No study locations are listed for this record.

07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01557205
Lead sponsor
National Taiwan University Hospital
Responsible party
National Taiwan University Hospital (Professor, National Taiwan University) — Principal investigator
First posted
Mar 19, 2012
Start date
Mar 2012
Primary completion
Apr 2013 (estimated)
Completion
Apr 2013 (estimated)
Last update
Mar 19, 2012

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion